Horizon Oncology Center

1345 Unity Place, Suite 345 - Lafayette, IN 47905

For information about clinical trials being conducted in Lafayette, IN, please contact Linda Vaders at 765.446.5111.

Wael Harb, MD (Principal Investigator)

Trials at this Location:

Disease: Banking / Biorepository
A Biological Sample Collection Protocol of Patients with and without Metastatic Solid Organ Malignancies - BNK09-138
Status: Suspended to Accrual 4/21/2011; Original Open Date 10-06-2009
More Details

Disease: Breast
PARP Inhibition after Preoperative Chemotherapy in Patients with Triple Negative Breast Cancer or ER/PR +, HER2 negative with known BRCA1/2 Mutations - BRE09-146
Status: Opened 2/22/2010;
More Details

Disease: Kidney
Phase I/II Study of BNC105P in Combination with Everolimus or Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma Following Prior Tyrosine Kinase Inhibitors. - GU09-145
Status: CONFIDENTIAL - Please contact Project Manager
More Details

Disease: Lung
A Randomized Double Blind Phase II Trial of Cisplatin plus Etoposide with/without Concurrent ZD6474 in Patients with Previously Untreated Extensive Stage Small Cell Lung Cancer - LUN06-113
Status: Open to Accrual - 01-23-2008
More Details